DCI

DCI
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $980.7M ▲ | $187.1M ▼ | $114.3M ▲ | 11.655% ▲ | $0.98 ▲ | $181.2M ▲ |
| Q3-2025 | $940.1M ▲ | $234.5M ▲ | $57.8M ▼ | 6.148% ▼ | $0.49 ▼ | $117.3M ▼ |
| Q2-2025 | $870M ▼ | $180.4M ▼ | $95.9M ▼ | 11.023% ▲ | $0.8 ▼ | $155.9M ▼ |
| Q1-2025 | $900.1M ▼ | $188.8M ▲ | $99M ▼ | 10.999% ▼ | $0.83 ▼ | $161.5M ▼ |
| Q4-2024 | $935.4M | $188.6M | $109.7M | 11.728% | $0.91 | $169.6M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $180.4M ▲ | $2.977B ▼ | $1.524B ▼ | $1.454B ▼ |
| Q3-2025 | $178.5M ▼ | $2.997B ▲ | $1.532B ▲ | $1.464B ▼ |
| Q2-2025 | $189.1M ▼ | $2.961B ▼ | $1.417B ▼ | $1.544B ▲ |
| Q1-2025 | $221.2M ▼ | $3.044B ▲ | $1.501B ▲ | $1.543B ▲ |
| Q4-2024 | $232.7M | $2.914B | $1.425B | $1.489B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $114.3M ▲ | $167.8M ▲ | $-20.6M ▼ | $-146.3M ▼ | $1.9M ▲ | $147.5M ▲ |
| Q3-2025 | $57.8M ▼ | $87.7M ▼ | $-14.7M ▲ | $-86.9M ▲ | $-10.6M ▲ | $73M ▲ |
| Q2-2025 | $95.9M ▼ | $90.4M ▲ | $-19.1M ▲ | $-98.3M ▼ | $-32.1M ▼ | $71.5M ▲ |
| Q1-2025 | $99M ▼ | $72.9M ▼ | $-96M ▼ | $9.8M ▲ | $-11.5M ▼ | $47.9M ▼ |
| Q4-2024 | $109.7M | $126M | $-19.1M | $-98.4M | $9M | $106.2M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Life Sciences Segment | $70.00M ▲ | $70.00M ▲ | $70.00M ▲ | $80.00M ▲ |
Engine Products Segment | $570.00M ▲ | $550.00M ▼ | $580.00M ▲ | $0 ▼ |
Industrial Products | $260.00M ▲ | $250.00M ▼ | $280.00M ▲ | $0 ▼ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Overall, Donaldson looks like a mature, steadily growing industrial company with a strong niche in filtration and a long history of profitability. Sales and operating profits have climbed over the past five years, even though the latest year shows some pressure on earnings per share and cash flow versus a recent peak. The balance sheet is sound, with rising equity and manageable but gradually higher debt. Consistent free cash flow supports ongoing investment and shareholder returns. Strategically, Donaldson benefits from a defensible moat built on technology, aftermarket exposure, and tight OEM relationships, while its sustained R&D and push into life sciences, electrification, and connected solutions provide potential long-term growth drivers. The main things to watch are margin trends, the use of leverage, and the execution of its newer, higher-growth initiatives.
NEWS
November 21, 2025 · 2:50 PM UTC
Donaldson Company Announces Preliminary Results of Annual Meeting, Shareholders Elect New Director Dan Shine to Board of Directors
Read more
November 21, 2025 · 1:35 PM UTC
Donaldson Company Declares Quarterly Cash Dividend
Read more
November 7, 2025 · 7:00 AM UTC
Donaldson Company to Present at the Baird 2025 Global Industrial Conference
Read more
November 6, 2025 · 7:00 AM UTC
Donaldson to Webcast First Quarter Fiscal 2026 Earnings Conference Call
Read more
November 3, 2025 · 8:00 AM UTC
Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium
Read more
About Donaldson Company, Inc.
https://www.donaldson.comDonaldson Company, Inc. manufactures and sells filtration systems and replacement parts worldwide. The company operates through two segments, Engine Products and Industrial Products.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $980.7M ▲ | $187.1M ▼ | $114.3M ▲ | 11.655% ▲ | $0.98 ▲ | $181.2M ▲ |
| Q3-2025 | $940.1M ▲ | $234.5M ▲ | $57.8M ▼ | 6.148% ▼ | $0.49 ▼ | $117.3M ▼ |
| Q2-2025 | $870M ▼ | $180.4M ▼ | $95.9M ▼ | 11.023% ▲ | $0.8 ▼ | $155.9M ▼ |
| Q1-2025 | $900.1M ▼ | $188.8M ▲ | $99M ▼ | 10.999% ▼ | $0.83 ▼ | $161.5M ▼ |
| Q4-2024 | $935.4M | $188.6M | $109.7M | 11.728% | $0.91 | $169.6M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $180.4M ▲ | $2.977B ▼ | $1.524B ▼ | $1.454B ▼ |
| Q3-2025 | $178.5M ▼ | $2.997B ▲ | $1.532B ▲ | $1.464B ▼ |
| Q2-2025 | $189.1M ▼ | $2.961B ▼ | $1.417B ▼ | $1.544B ▲ |
| Q1-2025 | $221.2M ▼ | $3.044B ▲ | $1.501B ▲ | $1.543B ▲ |
| Q4-2024 | $232.7M | $2.914B | $1.425B | $1.489B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $114.3M ▲ | $167.8M ▲ | $-20.6M ▼ | $-146.3M ▼ | $1.9M ▲ | $147.5M ▲ |
| Q3-2025 | $57.8M ▼ | $87.7M ▼ | $-14.7M ▲ | $-86.9M ▲ | $-10.6M ▲ | $73M ▲ |
| Q2-2025 | $95.9M ▼ | $90.4M ▲ | $-19.1M ▲ | $-98.3M ▼ | $-32.1M ▼ | $71.5M ▲ |
| Q1-2025 | $99M ▼ | $72.9M ▼ | $-96M ▼ | $9.8M ▲ | $-11.5M ▼ | $47.9M ▼ |
| Q4-2024 | $109.7M | $126M | $-19.1M | $-98.4M | $9M | $106.2M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Life Sciences Segment | $70.00M ▲ | $70.00M ▲ | $70.00M ▲ | $80.00M ▲ |
Engine Products Segment | $570.00M ▲ | $550.00M ▼ | $580.00M ▲ | $0 ▼ |
Industrial Products | $260.00M ▲ | $250.00M ▼ | $280.00M ▲ | $0 ▼ |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Overall, Donaldson looks like a mature, steadily growing industrial company with a strong niche in filtration and a long history of profitability. Sales and operating profits have climbed over the past five years, even though the latest year shows some pressure on earnings per share and cash flow versus a recent peak. The balance sheet is sound, with rising equity and manageable but gradually higher debt. Consistent free cash flow supports ongoing investment and shareholder returns. Strategically, Donaldson benefits from a defensible moat built on technology, aftermarket exposure, and tight OEM relationships, while its sustained R&D and push into life sciences, electrification, and connected solutions provide potential long-term growth drivers. The main things to watch are margin trends, the use of leverage, and the execution of its newer, higher-growth initiatives.
NEWS
November 21, 2025 · 2:50 PM UTC
Donaldson Company Announces Preliminary Results of Annual Meeting, Shareholders Elect New Director Dan Shine to Board of Directors
Read more
November 21, 2025 · 1:35 PM UTC
Donaldson Company Declares Quarterly Cash Dividend
Read more
November 7, 2025 · 7:00 AM UTC
Donaldson Company to Present at the Baird 2025 Global Industrial Conference
Read more
November 6, 2025 · 7:00 AM UTC
Donaldson to Webcast First Quarter Fiscal 2026 Earnings Conference Call
Read more
November 3, 2025 · 8:00 AM UTC
Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium
Read more

CEO
Tod E. Carpenter
Compensation Summary
(Year 2025)

CEO
Tod E. Carpenter
Compensation Summary
(Year 2025)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2012-03-26 | Forward | 2:1 |
| 2004-03-22 | Forward | 2:1 |
| 1998-01-14 | Forward | 2:1 |
| 1994-04-07 | Forward | 2:1 |
| 1992-07-13 | Forward | 3:2 |
| 1988-05-03 | Forward | 2:1 |
| 1978-08-01 | Forward | 3:2 |
| 1976-08-03 | Forward | 1499:1000 |
Ratings Snapshot
Rating : B+
Most Recent Analyst Grades
Grade Summary
Price Target
Institutional Ownership

VANGUARD GROUP INC
12.039M Shares
$1.082B

BLACKROCK INC.
10.802M Shares
$971.075M

BLACKROCK, INC.
10.68M Shares
$960.155M

STATE FARM MUTUAL AUTOMOBILE INSURANCE CO
9.143M Shares
$821.921M

BLACKROCK FUND ADVISORS
5.074M Shares
$456.187M

STATE STREET CORP
5.049M Shares
$453.947M

FMR LLC
4.124M Shares
$370.741M

BLACKROCK INSTITUTIONAL TRUST COMPANY, N.A.
4.002M Shares
$359.768M

STATE FARM INVESTMENT MANAGEMENT CORP
3.672M Shares
$330.104M

KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC
3.2M Shares
$287.682M

GEODE CAPITAL MANAGEMENT, LLC
2.831M Shares
$254.466M

BOSTON TRUST WALDEN CORP
2.703M Shares
$242.975M

MORGAN STANLEY
2.495M Shares
$224.31M

FIDUCIARY MANAGEMENT INC /WI/
2.476M Shares
$222.556M

DIMENSIONAL FUND ADVISORS LP
1.994M Shares
$179.28M

FULLER & THALER ASSET MANAGEMENT, INC.
1.729M Shares
$155.453M

AMERICAN CENTURY COMPANIES INC
1.498M Shares
$134.665M

FIRST TRUST ADVISORS LP
1.439M Shares
$129.364M

INVESCO LTD.
1.335M Shares
$119.987M

BANK OF NEW YORK MELLON CORP
1.283M Shares
$115.371M
Summary
Only Showing The Top 20





